As the cannabis rescheduling process progresses and we enter the fourth quarter of 2024, many cannabis businesses are wondering what’s next and how rescheduling may impact 280E and tax planning.
In this session, Vicente...more
I recently traveled to Amsterdam to participate in an expert seminar on European cannabis and drug policy. The seminar covered various topics, including a thought experiment on where European Union (EU) cannabis reform was...more
7/26/2024
/ Agribusiness ,
Czech Republic ,
Decriminalization of Marijuana ,
EU ,
Germany ,
Malta ,
Marijuana ,
Marijuana Cultivation ,
Marijuana Related Businesses ,
Netherlands ,
Personal Use ,
Recreational Use ,
Switzerland ,
THC
After 50 years of being on the most restrictive schedule alongside drugs like heroin and PCP, the DEA will move to reschedule marijuana in Schedule III, where the plant’s medical benefits will finally be recognized by the...more
5/1/2024
/ Agribusiness ,
Controlled Substances Act ,
Corporate Counsel ,
DEA ,
Decriminalization of Marijuana ,
Department of Justice (DOJ) ,
Financial Services Industry ,
Food and Drug Administration (FDA) ,
Marijuana ,
Marijuana Related Businesses ,
Medical Marijuana ,
Medical Research ,
Popular ,
Schedule I Drugs